Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1

Sleep Medicine 2026

View at publisher
Authors: Giuseppe Plazzi, Yves A Dauvilliers, RR Grunstein, Emmanuel Jean-Marie Mignot, G.J. Lammers, DT Plante, Erik Buntinx, Rafael del Río Villegas, H. Chen, A. Lovett, Craig Hopkinson, Bhaskar Rege
+1 more M. Yountz
DOI: 10.1016/j.sleep.2025.107571
Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Obstructive Sleep Apnea Research

Publication details

Journal / source
Sleep Medicine
Volume
138
Pages
107571–107571
Publication date
29 January 2026
Language
EN